In conclusion, our results suggest imatinib administration improves bladder function (e.g., IMI and IV) in mice with acute CYP-induced cystitis by a prevention (gavage; females) and treatment (intravesical infusion; females and males) experimental design. This evidence concerns the gene PPIG and chronic cystitis.